FSSAI issues notices to Nestle, Zydus over 'misleading' claims

The Food Safety and Standards Authority of India (FSSAI) has issued notices to Nestle and Zydus concerning what it describes as "misleading" claims made by the companies. This action by the FSSAI underscores its regulatory oversight regarding product advertising in the health sector.

Specifically, the FSSAI flagged a claim made by Nestle stating that "5 HMOs helps support normal immune system." The regulatory body expressed concern that this assertion could be interpreted by consumers to mean the product is effective in supporting immunity specifically for a particular physiological condition.

The FSSAI's intervention highlights the importance of clear and unambiguous communication in product labeling and marketing, particularly for items making health-related claims.

What to watch: Further actions by FSSAI regarding product claims.

Editor's note: The draft accurately conveys the FSSAI's position, though it could have been strengthened by mentioning Zydus's specific claims, which are absent from the provided summary.